These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4585954)

  • 61. The susceptibility of Serratia marcescens to sulfamethoxazole, trimethoprim, and trimethoprim-sulfamethoxazole.
    Adeniyi-Jones C; Neilly S; Roberts RS; Kaufmann NR
    J Infect Dis; 1973 Nov; 128():Suppl:534-42 p. PubMed ID: 4585956
    [No Abstract]   [Full Text] [Related]  

  • 62. Escherichia coli in urinary tract infections in Sudanese patients.
    Erwa HH
    Trop Geogr Med; 1972 Jan; 24(1):60-5. PubMed ID: 4551336
    [No Abstract]   [Full Text] [Related]  

  • 63. The action of bacteriophage omega 8 on two strains of Escherichia coli 08.
    Wallenfels B; Jann K
    J Gen Microbiol; 1974 Mar; 81(1):131-44. PubMed ID: 4595511
    [No Abstract]   [Full Text] [Related]  

  • 64. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 65. Pseudomonas cepacia tricuspid endocarditis: treatment with trimethoprim, sulfonamide, and polymyxin B.
    Rahal JJ; Simberkoff MS; Hyams PJ
    J Infect Dis; 1973 Nov; 128():Suppl:762-7 p. PubMed ID: 4357095
    [No Abstract]   [Full Text] [Related]  

  • 66. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 67. A comparison of the antibacterial activity of sulphonamide-trimethoprim combinations.
    Fourie ED; van Straten AM; Maritz HC; van Rensburg AJ
    S Afr Med J; 1979 Mar; 55(14):544-7. PubMed ID: 377523
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synergistic antibacterial activity in vitro of trimethoprim and sulphonamides and the importance of pharmacokinetic properties for optimal therapy.
    Seydel JK; Wempe E
    Infection; 1979; 7 Suppl 4():S313-20. PubMed ID: 389807
    [No Abstract]   [Full Text] [Related]  

  • 69. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effects of trimethoprim and its antagonists on RNA synthesis in Escherichia coli].
    Then R; Angehrn P
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):762. PubMed ID: 4560667
    [No Abstract]   [Full Text] [Related]  

  • 71. Effects of trimethoprim and its antagonists on RNA synthesis in Escherichia coli.
    Then R; Angehrn P
    Biochim Biophys Acta; 1972 Nov; 287(1):98-105. PubMed ID: 4569161
    [No Abstract]   [Full Text] [Related]  

  • 72. [Antibiotics and chemotherapeutic agents--from research to practice. IV. Remarks to the practitioner on the peculiarities of trimethoprim and its combination with sulfonamides].
    Pilloud M
    Schweiz Arch Tierheilkd; 1982 Jun; 124(6):307-14. PubMed ID: 7123185
    [No Abstract]   [Full Text] [Related]  

  • 73. Trimethoprim-sensitivity testing and thymineless mutants.
    Amyes SG; Smith JT
    J Med Microbiol; 1974 May; 7(2):143-53. PubMed ID: 4209268
    [No Abstract]   [Full Text] [Related]  

  • 74. Influence of sulfonamide antagonists on the synergism of sulfamethoxazole-trimethoprim in Escherichia coli.
    Then R
    Zentralbl Bakteriol Orig A; 1973 Oct; 225(1):34-41. PubMed ID: 4148900
    [No Abstract]   [Full Text] [Related]  

  • 75. Biochemical effects of nalidixic acid on Escherichia coli.
    Bauernfeind A; Grümmer G
    Chemotherapy; 1965-1966; 10(2):95-102. PubMed ID: 5325144
    [No Abstract]   [Full Text] [Related]  

  • 76. Inhibition by pluramycin A of nucleic acid biosynthesis.
    Nagai K; Yamaki H; Tanaka N; Umezwa H
    J Biochem; 1967 Sep; 62(3):321-7. PubMed ID: 4869973
    [No Abstract]   [Full Text] [Related]  

  • 77. Resistance to trimethoprim in Klebsiellae isolated before its introduction.
    Hamilton-Miller JM; Grey D
    J Antimicrob Chemother; 1975 Jun; 1(2):213-8. PubMed ID: 1100591
    [No Abstract]   [Full Text] [Related]  

  • 78. Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole.
    Yourassowsky E; Vanderlinden MP; Schoutens E
    J Clin Pathol; 1974 Nov; 27(11):897-901. PubMed ID: 4613734
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of bilharcid and tartar-emetic on DNA, RNA and protein synthesis in Escherichia coli B.
    Khafagy EZ; el-Hawary MF
    Biochem Pharmacol; 1974 May; 23(10):1451-5. PubMed ID: 4603209
    [No Abstract]   [Full Text] [Related]  

  • 80. The assessment of antimicrobial combinations.
    King TC; Schlessinger D; Krogstad DJ
    Rev Infect Dis; 1981; 3(3):627-33. PubMed ID: 7025154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.